Tuesday, January 16, 2024

Two stocks to watch in THE Defense of AMERICA and the FREE WORLD

 

Market Talk
Many people on Main Street America are not aware of the new dangers to America. Just as one example - a very serious- lack of keeping up with China's advances in weapons of mass destruction.

China has made advances in hypersonic missiles (tagged as "DF-") that are designed (and already deployed) to rain down terror from the upper regions of the atmosphere at hyper-sonic speeds.  That Chinese balloon that took low altitude pictures of silos in Montana?   For years, the theory of mutually assured destruction has kept nuclear war at bay. If China gets the notion that they can quickly take out a major leg of our nuclear triad, land based missiles, submarine and strategic bombers then there could be crazy forces that start believing a first strike could gain them advantage. If "they" start believing they could take out our command and control before we can fully strike back ?  Be aware America.  Thanks to two America companies - all may not be lost. 
Let us proceed to stock talk.

Stock Talk

There are two American companies that are world leaders in the defense of America and our allies in free countries. Now, the two companies are into a diverse array of products and division.  For the purpose of this post , we will focus on the anti- missile systems that make up a sort of "dome of protection" for free countries defense against aggression by nefarious forces.

Enter Raytheon and Lockheed Martin.  Raytheon Corporation (RTX) is lead on the Patriot anti-missile system. Lockheed Martin (LMT) is lead on THAAD. Terminal High Altitude Area Defense Missile system.  Both anti missile systems can be deployed to help take out missiles, even hypersonic missiles. Our adversaries, China and Russia, Iran as well as North Korea HATE the Patriot and THAAD defense systems.

As far as stocks . LMT is already over $400 a share. Here at the Jones report, it's considered out of range, but a watch stock. On the other hand - Raytheon (RTX) could be an interesting stock to maybe start to take a small position in the 80's.  Not saying to go all in but maybe a few shares of RTX here n' there in dollar cost averaging  mode could be a good investment.

If the notion of the added deterrent of an "iron dome" all around America takes hold -  RTX and LMT would be key players.

This post will close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Friday, December 22, 2023

The Fed "pivot" is waking "Elephants in the room" - as the year winds down and related "Stock Talk".

 

Market Talk
The other day, the Federal reserve chairman made a surprising "pivot" on interest rate guidance.  New suggestions that as inflation comes under control, there will likely be coming rate cuts as early as the spring. The market immediately went bonkers higher, only to retreat backward as the ebullience wore down to reality of more circumspect views on soft landing vs hard landing prospects.


Regardless, the market will continue its unpredictable ways, but fundamentals still matter as far as individual stocks.

At the winter solstice, it seems high time to let the elephants in the room air it out. Here is just one elephant, there are many in the room.

In addition to inflation, the strength of US dollar may be waning globally. The BRICS are systematically creating go arounds from using the US dollar as a means of trade.  This post will discuss near term actions that may or may not be prudent. BUT not being aware is not a good strategy.
 
Let us proceed to stock talk.

Stock Talk

With the Federal Reserve pivot, it may indicate to investors that the inflation encountered is just going to become MORE prevalent. Inflation is a hidden tax as well. The need "to get ahead of the bum's rush " maddens to make more money to overcome the high taxes.

There are stores of value that various groups believe will increase .  The millennials are stuck on one area: Crypto and it's mainstay - Bitcoin.

Now one elephant is as a stock watcher that many of us watched from the sidelines here and there as bitcoin waivered.  In a short span of a month, bitcoin has shot higher into the $43,000 range. There is a "halving" planned in April 2024.  This is where it becomes twice as hard for "the miner's" computers to solve the puzzles that create bitcoin ownership.  The notion is that it is a natural way to prevent dilution of bitcoin value.  This is one thing that makes bitcoin valuable in the minds of crypto enthusiasts. Unlike "fiat" or government currency that is backed only on the good faith of the particular nation.

In a short span, bitcoin related stocks, specifically "the miners" have seen surges some tripling.  At the same time, they are not yet near their previous highs during the bitcoin bubble.  With the halving, bitcoin miners costs rise to get the same bitcoin they mine today by double.  But many are taking steps to increase development capacity by buying more equipment, facilities near energy efficient nuclear power plants.

An elephant is the question of did many of us actually miss the run and will bitcoin heat burn off as whales take gains along the way.  One factor driving crypto is government acceptance.  There is a plan for Blackrock, Wisdom tree and others to start spot ETF bitcoin vehicles.  Applications are submitted to the SEC and adjustments are being worked such cash vs margin requirements.

So, the question of the future is there still time get involved? Or is crypto a passing fad like tulips in Holland that could sell off harshly?

Halving will theoretically increase the value of Bitcoin as long as people still want it.  Bitcoin is NOT like a gold coin you can pick up and hold.  It's notional "bits" on a storage device that can be bought and sold in the ether at on-line brokers like coinbase.

https://finance.yahoo.com/news/crypto-had-a-surprisingly-great-year-it-still-faces-threats-in-2024-100021572.html

Some symbols:

COIN

Some bitcoin miners:

MARA

RIOT

CLSK

The symbols above have ALREADY broken out considerably.  Could they go even further or create new bag holders?  Only the future can say.

This is where the words maybe "watch" and if ready to actually pull the trigger?   Only "some if any" applies based on your own appetite for risk.  Maybe if "trying to trade" the swing, a trade in some like MARA could work.

Stay tuned for other stocks where elephants in the room are moving such as defense and oil stocks. Topics for another day. 

Defense:  RTX,  LMT

and today, we have an update in Vital Resources, highlighted here as a stock to watch.

https://finance.yahoo.com/news/vital-energy-acquires-additional-working-220000237.html


Vital Energy (VTLE):

Vital reported quarterly eps:  $5.16 with over 200,000 acres of oil rich property in the basins of America. very high eps, very low pe. 

Comparing eps makes VTLE interesting indeed.  They are reported to have hedged oil in the 70's.  VTLE is a takeover candidate as well with recent consolidations happening by big oil. 

Fundamentals on VTLE seem very strong although the recent market variations have not been pleasant to shareholders. It may be time to bottom fish on some VTLE?

... and holding some METC and METCB

This post will close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Thursday, December 14, 2023

Paint a rosy picture ride a painted pony...yea ok sure.

 


Market Talk
 

The Fed is pivoting their inflation fighting story to an easing of interest rates.

"US stocks gained on Thursday, as investors continued to celebrate a dovish shift by the Federal Reserve that helped propel the Dow to a new all-time closing high."

Has inflation really subsided?  Things still cost way too much. In other words. prices are not really coming down.  It makes one wonder if the Fed is changing their tune to help the current politicians in office for 2024 elections.  Anybody that is aware of how "they" are selling out America for power and bold face pony dog lying to us would be circumspect. Oh, and don't forget the democrat's line, "the border is secure".  yea sure - 10,000 a day on a bus to anywhere?

Paint a rosy picture and ride a painted pony let the spinning wheels turn.

https://www.youtube.com/watch?v=P5jNJd7HRVU


Stock watching today shows the financials bouncing higher. Bank stocks must like it.

I close this post by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Tuesday, November 14, 2023

The buck fifty Cinderella man stock readies for the PRIZE FIGHT OF THE DECADE - in a coming $5 Mil study

 

 
Special Edition

Many have seen the true story movie about "Cinderella man", James J. Braddock. Wow, what a story of a man in the 1930's as a light heavyweight boxer was forced by a hand injury to work on the docks or anywhere he could find work.  He had to turn to welfare for his family and even in humble begging to his former promoters. Here is a scene from the movie.

https://www.youtube.com/watch?v=JCKh3Jsge4E

Braddock's hand slowly healed but had to beg again to get back into the arena.  Very few believed he had the fight left in him to make it and he and his family looked to be "down and out".  "Get him a fight scene"...

https://www.youtube.com/watch?v=e4fb7N_ICj0

After many years of struggling, Braddock surprised the fight world in a comeback as a contender.  The heavy weight champion of the time was Max Baer, who agreed to fight James and brashly scoffed and mocked him in fight promotions. Indeed, two of Baer's opponents had died from Baer's powerful punches to the head. Many feared for Braddock's life as a light heavy now fighting in the heavyweight range against none other than the brash Max Baer.

https://www.youtube.com/watch?v=HGU3PRBxQiw

"James J. Braddock fought Max Baer on June 13, 1935, at the Long Island City Bowl in New York City 1. Braddock was a former light heavyweight who had suffered many losses and hardships during the Great Depression. He was a 10-1 underdog going into the fight against Baer, who was known for his heavy-hitting power. However, Braddock pulled off a stunning upset by outboxing and outworking Baer for 15 rounds, winning the world heavyweight championship. "

____

Now WHAT Pray tell does the Cinderella man story have to do with a stock? 

Oncolytics Biotech (ONCY):

Many years conducting clinical trials with their lead immune candidate research, study and trials to advance their lead drug Pelareorep (Pela) as an immune platform to fight the most aggressive forms of cancer such as pancreatic, met-breast, colorectal cancer. "Many years"

Scanning technology is recently showing evidence of Pela treatment causing patient's own immune T fighter cells to duplicate in multitudes and attack and kill cancerTo date, there are two reported Complete responses (CRs) after Pela treatment- patient C1-013 fighting Pancreatic Cancer and another CR against anal cancer in the trial named Goblet.

https://d1io3yog0oux5.cloudfront.net/_be9de2668869b0cb6e0b8d4461a0c77c/oncolyticsbiotech/db/300/2609/pdf/Oncolytics+Presentation+August.pdf


https://finance.yahoo.com/news/oncolytics-announces-anal-cancer-cohort-120000764.html

Recently, the Pan Can organization has changed strategy regarding advancing Pela in the Phase 3 clinical trial.  While the market is knee jerked on the news, backers view the change as possibly beneficial.  The $5 mil sponsored study with Pela immune Fight platform alone combined with a modified Chemo will be a true measure of Pela's immune boosting effectivity along with Chemo that attacks cancer but can be hard to take.  "good cop/ bad cop" approach in the cancer fight.  Studying Pela combined with a modified Chemo with or without a checkpoint inhibitor, if positive, could result in a completely new treatment option for millions of cancer fighters all around the world.  If positive study results, the Pela + Chemo combo could be a multi-$ Billion boon to ONCY's prospects.

To be more precise about the coming fight -- the previous ONCY IR reply:

"This $5 million grant will enable Oncolytics to continue the next stage of its research focused on a clinical trial with Oncolytics’ proprietary reovirus pelareorep in combination with modified FOLFIRINOX chemotherapy with or without an immune checkpoint inhibitor. If results are encouraging, the treatment combination may be advanced to late-stage clinical development through the PanCAN Precision Promise adaptive clinical trial platform."


ONCY is a spec stock in the small cap bio -tech arena under $2 stock.  For readers that can take the variances and whims of knee jerk traders, the Jones view is "stay long" on the Mechanism of Action for fighters of cancer.

Like in the movie -- "Sometimes ya have an instinct , mae. you see something in a fighter ".

Conclusion:  There is a prize fight coming to the world of cancer treatments for a most aggressive Pancreatic Cancer.  In early 2024 the study is planned to use Pela immune treatment with Chemo alone on Pancreatic cancer fighters that sign up.  While exact planning is a little vague at this point, it should start to become clearer within a few months.

As a stock, the Jones report view is that ONCY should be treated as a "spec stock".  However, compelling evidence of a few CRs, immune T - fighter cell scans, and meeting statistical success in the Phase 1/2 trials is raising the instinct to be in "some" not "too much" and stay long as long as the Pela Treatment Mechanism of Action (MOA) continues to be proven.  The small $5 mil study with ONCY working with the Pan Can network could be a dovetail of Pela into a Phase 3 fast-track trial.  If compelling, other options will exist for ONCY as well (like a Bp buyout offer?). If compelling, look for the stock to rise significantly. At the same time, we small investors say - not "too much" on spec stocks.  We know not to put too much skin in any spec stock.  It takes time...

For those that have a few hundred bucks laying around and have "an instinct" that Pela can be proven to play a key role as an immune component of the cancer fight, pick up a hundred or so of ONCY shares and go long as long as Pela is a contender.  Spread the word to like-minded stock watchers.  The Jones target is $60 and higher if Pela treatment proves out in further tests - and the $5 Mil Pan Can sponsored study could be the spark to ignite a rocket.   The real goal is the whole enchilada - to give cancer fighters a new shot of hope.

God bless to the real pancreatic cancer fighters that sign up for the study.

This post will close by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Tuesday, October 17, 2023

Ramaco Resources, METC and METCB UPDATE - WoW

 

Stock Talk

 
Ramaco Resources (METC and METCB)  has been highlighted here in several posts as a stock to watch.  It was noted that METC and METCB Ramaco are under recognized and was practically pounding the table as a "some" stock.  Well, we see quite an interesting update today. Fundamentals matter and add the update to the vast rare earths resources found in the Wyoming property.  Ramaco looks back on track in quite an impressive way. I don't need to prove my point today, read the Ramaco update and see what YOU think.


Here is a Jones report highlight posted back in July.


I close this post by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Monday, October 2, 2023

Circumspect Monday : "some" vs "too much" - and Dry powder.

 

Market Talk
 

Sometimes maybe you just get "a feeling" about things. In the market, it seems that most stocks are just floating about with no clear winners.  Even the pundits come out with their pumps on the flashy or trendy stocks like in artificial intelligence (AI) software.  These pumps can cause the stock to surge a week, but then when you start looking at their financials and the reality of management and high costs and losing in earnings, eps, it points out glaring hyped up prices.  And true to nature of a fickle market, the hyped AI stocks correct as traders sell.

After every post here there is note about watching how things work out to our prognostications.  There are many factors that can waylay outlook.  One important point about trying to look a few months ahead is that we do not get arrogant by putting "too much" on our projections, predictions and hope.  We always say "some" on any one stock and not "too much".

There is one factor that can affect any bullish prediction -  Short sellers. The other is insider greed to take more than the company's results warrant. That goes for any stock.

I will likely  post more on the above later.  For now, looking at the overall market, world events, the fed's calling - it seems time to become more circumspect.  The words "some" not "too much" still resonates here and if "too much" , it may be time to adjust.


Stock Talk
 
 
When things seem more dicey in the overall market, sometimes we use the words "dry powder" .  This does not mean panic and sell all of the stocks we may have "some", but if "too much" ?  Well, each stock watcher has to consider their own situation.  
 
I will wrap this up by pointing to a previous post on a possible "dry powder" vehicle, USFR,  to weather a downturn in a high interest climate.
 

I close this post by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________

Monday, July 31, 2023

Does Nerdy stock have the AI hype and juju to catch more momo on fomo?

  Market Talk


The many pundits are taking a recession "off the table" for the remaining part of this year.  Some leave open the distinct possibility for the R word next year. The markets are enjoying a run in the various indices.  Many investors now have a case of fear of missing out or fomo for short.  Perhaps sheer fomo will drive the markets higher for awhile until the next roadblock to stock value prosperity shows up. We will dismiss discussion on roadblocks for the time being. Far be it from moi to be the party pooper in the mix.
 
 
Stock Talk
 
The two buzz words of the time are "Artificial intelligence" or simply AI.  JP Morgan has picked a stock called NERDY or symbol NRDY in the AI space. Is it a fomo buy?

The stock NRDY has already nearly doubled in one month trading at near $5 a share today.  It is in the online teaching space of a multitude of subjects. The previous quarter saw a revenue beat but an earning miss of 4 cents per share for a loss of 21 cents per share. Yet, JP Morgan analysts are endorsing NRDY as a buy now stock.


Does Nerdy stock have the AI hype and juju to catch more momo on fomo?

We will have to watch NRDY stock to see how their 2nd  quarter earnings play out in their coming August 8 report. 
 
I close this post by noting that any view on the market and stocks on any particular day may change in the future days to come. That is why we watch and see how our views match up with the reality of the time.  But trying to look ahead a few months into the future may be a way to do things.  If you think too deep about world events and the recent alliances forming, projecting ahead can be a dicey endeavor. With all the above caveats and attempted prognostications, I will close this post. 

Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.
This site does NOT make Buy / Sell recommendations.
_____________